Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07481396

Molecular Insights Into Post-Cardiac Arrest Brain Injury Via CSF Multi-Omics

Identification of Novel Molecular Pathophysiological Mechanisms of Secondary Brain Injury in Post-cardiac Arrest Syndrome Patients Using Cerebrospinal Fluid Multi-omics Analysis

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Chungnam National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to uncover the molecular mechanisms responsible for secondary brain injury in patients with post-cardiac arrest syndrome by analyzing cerebrospinal fluid (CSF) using multi-omics techniques. The main question this study aims to answer is: Which genome-, transcriptome-, proteome-, and metabolome-level changes in CSF are associated with secondary brain injury after cardiac arrest? To address this question, CSF samples collected from post-cardiac arrest patients will undergo multi-omics analyses. Identified molecular pathways will be used to screen existing drug databases and generate new therapeutic candidates through computational modeling and compound synthesis. These findings will provide the scientific foundation needed to design and implement future preclinical experiments using cardiac arrest animal models.

Conditions

Timeline

Start date
2025-12-01
Primary completion
2027-11-30
Completion
2028-02-28
First posted
2026-03-18
Last updated
2026-03-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07481396. Inclusion in this directory is not an endorsement.